Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S ...
TipRanks on MSN
Mesoblast’s U.S. Origin Cell Therapies Exempt from Tariffs
Mesoblast Limited ( ($AU:MSB) ) has provided an announcement. Mesoblast Limited announced that its allogeneic cell therapy products, manufactured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback